-
Dr. Yohan KERBAGE defended his HDR on 24 September 2024
On 24 September, Dr Yohan KERBAGE defended his habilitation to direct research (HDR) at the Lille Faculty of Medicine: « Cancers gynécologiques et mammaires : de la recherche clinique [...]
-
Article accepted in the journal Biomedicines
Onco Thai publishes a new article in the journal Biomedicines We are pleased to announce that the article entitled « Photodynamic Therapy Using a Rose-Bengal Photosensitizer for Hepatocellular [...]
-
Defense of Laurine Nieuwjaer Ziane thesis - September 26, 2023
Laurine Ziane defended her PhD thesis entitled « Develepment of a light emitting device for the treatment of ovarian peritoneal carcinomatosis by intracavitary photodynamic therapy »
Clinical tests
Enrollment phase of INDYGO is now successfully achieved
After the inclusion of 10 patients, the first step of the INDYGO study is now completed, enabling the analysis of data collected during the trial
Rare diseases foundation and OncoThAI
OncoThAI and the Photodynamic Therapy Awarded by the french Rare Diseases foundation and SATT Nord
Photodynamic Therapy and OncoThAI illustrated in Nature journal
The INDYGO clinical trial by OncoThAI described in the last issue of the Nature Journal
Authorizations for the PAGETEX clinical trial
The French regulatory agencies (ANSM and CPP) authorize our clinical trial on the photodynamic treatment of the Paget's disease.
End of the evaluation of the PHOSISTOS® project
Evaluation of the PHOS-ISTOS® project completed, with a very favorable opinion from the European Commission
Start of the PAGETEX clinical trial
The first patient with Paget's disease has been treated by the PAGETEX clinical protocol.
